SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-005701
Filing Date
2022-01-31
Accepted
2022-01-31 17:38:24
Documents
2
Period of Report
2022-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1569
2 POA DOCUMENT poa.txt EX-24 2021
  Complete submission text file 0001209191-22-005701.txt   5095
Mailing Address C/O KYTHERA BIOPHARMACEUTICALS, INC. 27200 WEST AGOURA ROAD, SUITE 200 CALABASAS CA 91301
Business Address
Smither John W (Reporting) CIK: 0001559583 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39306 | Film No.: 22575425

Mailing Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080
Business Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080 650-392-0420
Applied Molecular Transport Inc. (Issuer) CIK: 0001801777 (see all company filings)

IRS No.: 814481426 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations